Vnitr Lek 2017, 63(3):161-162 | DOI: 10.36290/vnl.2017.033

Kardio-onkologie, onko-kardiologie - editorial

Lubomír Elbl
Privátní kardiologická ambulance, Brno

Received: February 12, 2016; Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Elbl L. Kardio-onkologie, onko-kardiologie - editorial. Vnitr Lek. 2017;63(3):161-162. doi: 10.36290/vnl.2017.033.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Curigliano G, Cardinale D, Dent S et al. Cardiotoxicity of Anticancer Treatments: Epidemiology, Detection, and Management. CA Cancer J Clin 2016; 66(4): 309-325. Dostupné z DOI: <http://dx.doi.org/10.3322/caac.21341>. Go to original source... Go to PubMed...
    2. Cuomo JR, Sharma GK, Conger PD et al. Novel concepts in radiation-induced cardiovascular disease. World J Cardiol 2016; 8(9): 504-519 Go to original source... Go to PubMed...
    3. Herrmann J, Lerman A. An Update of Cardio-Oncology. Trends Cardiovasc Med 2014; 24(7): 285-295. Dostupné z DOI: <http://dx.doi.org/10.1016/j.tcm.2014.07.003>. Go to original source... Go to PubMed...
    4. Zamorano JL, Lancellotti P, Daniel Rodriguez Muňoz DR et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur J Heart Failure 2016; 19(1): 9-42. Dostupné z DOI: <http://dx.doi.org/10.1002/ejhf.654>. Go to original source... Go to PubMed...
    5. Aleman BMP, Moser EC, Nuver J et al. Cardiovascular disease after cancer therapy. EJC 2014; 12(1): 18-28. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ejcsup.2014.03.002>. Go to original source... Go to PubMed...
    6. Bovelli D, Plataniotis G, Roila F. [ESMO Guidelines Working Group]. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol 2010; 21 (Suppl 5): v277-v282. Dostupné z DOI: <http://dx.doi.org/10.1093/annonc/mdq200>. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.